The Net Margin of BioMark Diagnostics Inc (BUX.CN) is -874.52%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | -874.52% |
| 2023-03-31 | -1200.23% |
| 2022-03-31 | -3309.58% |
| 2021-03-31 | -461.59% |
| 2020-03-31 | -31816.78% |
| 2019-03-31 | - |